Vertex Pharmaceuticals
VRTX
397,56 €
Share price
-1.88%
Change (1 day)
-13.65%
Change (1 year)
Categories
EPS for Vertex Pharmaceuticals (VRTX)
EPS in 2025 (TTM): -3,59 €
According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -3,28 €. In 2024 the company made an earnings per share (EPS) of -1,78 € a decrease over its 2023 EPS that were of 12,11 €.
EPS history for Vertex Pharmaceuticals from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -3,59 € | 101.97% |
| 2024 | -1,78 € | -114.67% |
| 2023 | 12,11 € | 8.17% |
| 2022 | 11,20 € | 42.64% |
| 2021 | 7,85 € | -12.67% |
| 2020 | 8,99 € | 128.01% |
| 2019 | 3,94 € | -44.54% |
| 2018 | 7,11 € | 670.09% |
| 2017 | 0,92 € | -327.66% |
| 2016 | -0,41 € | -79.65% |
| 2015 | -1,99 € | -26.43% |
| 2014 | -2,71 € | 53.92% |
| 2013 | -1,76 € | 316.33% |
| 2012 | -0,42 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 4,12 € | -225.79% | 🇺🇸 USA |
 AbbVie ABBV | 2,03 € | -162.04% | 🇺🇸 USA |
 Merck MRK | 5,95 € | -281.51% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,31 € | -170.53% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 7,82 € | -338.62% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | -3,92 € | 19.47% | 🇺🇸 USA |